批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2018/01/29 |
SUPPL-9(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2012/09/25 |
SUPPL-8(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2000/10/31 |
SUPPL-5(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1992/11/04 |
SUPPL-4(补充) |
Approval |
Labeling |
|
|
|
1991/12/04 |
SUPPL-3(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1989/01/19 |
ORIG-1(原始申请) |
Approval |
|
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:SODIUM POLYSTYRENE SULFONATE 剂型/给药途径:POWDER;ORAL, RECTAL 规格:454GM/BOT 治疗等效代码:AA
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
089910 |
001 |
ANDA |
SODIUM POLYSTYRENE SULFONATE |
SODIUM POLYSTYRENE SULFONATE |
POWDER;ORAL, RECTAL |
454GM/BOT |
Prescription |
No |
No |
AA |
1989/01/19
|
CMP PHARMA INC |
040029 |
001 |
ANDA |
KIONEX |
SODIUM POLYSTYRENE SULFONATE |
POWDER;ORAL, RECTAL |
454GM/BOT |
Prescription |
No |
No |
AA |
1998/02/06
|
ANI PHARMS |
040905 |
001 |
ANDA |
KALEXATE |
SODIUM POLYSTYRENE SULFONATE |
POWDER;ORAL, RECTAL |
454GM/BOT |
Prescription |
No |
Yes |
AA |
2009/03/30
|
KVK TECH |
204071 |
001 |
ANDA |
SODIUM POLYSTYRENE SULFONATE |
SODIUM POLYSTYRENE SULFONATE |
POWDER;ORAL, RECTAL |
454GM/BOT |
Prescription |
No |
No |
AA |
2014/11/28
|
NUVO PHARMS INC |
206815 |
001 |
ANDA |
SODIUM POLYSTYRENE SULFONATE |
SODIUM POLYSTYRENE SULFONATE |
POWDER;ORAL, RECTAL |
454GM/BOT |
Prescription |
No |
No |
AA |
2016/02/18
|
CHARTWELL RX |
205727 |
001 |
ANDA |
SODIUM POLYSTYRENE SULFONATE |
SODIUM POLYSTYRENE SULFONATE |
POWDER;ORAL, RECTAL |
454GM/BOT |
Prescription |
No |
No |
AA |
2016/02/23
|
BELCHER |